CRISPR Medicine News, 16 October 2020 | - CRISPR Medicine

Your missing links are here

Top Pick

  • In the wake of her recent Nobel Prize, Jennifer Doudna is up for more. In a talk with Future Human, she shares her ideas of how much more we can expect from CRISPR in the clinic. Among other visionary ideas, she thinks we will see a move from editing genomes to regulating them instead.

Nobel Prize

  • Even though you probably already know everything about CRISPR - the genome editing technology that was the cornerstone of this years' Nobel Prize in Chemistry - you might find it useful or at least entertaining to watch this animated video. It gives an excellent description of what CRISPR is all about and how researchers became aware of its tremendous potential.
  • The Nobel Prize is a hugely prestigious award, and many top researchers aspire for it. So it's no wonder that the internet has flourished with speculations about whether others than Emmanuelle Charpentier and Jennifer Doudna deserve a slice of the prize, e.g. Feng Zhang, Virginijus Siksnys, or Rodolphe Barrangou and Philippe Horvath. Read a brief description of who contributed with what in the Wire.


Delivery & Safety



  • The genome engineering company Synthego has developed a platform that uses CRISPR to accelerate the study of potential treatment targets for SARS-CoV-2. The platform compares host-virus protein interaction networks and is described in a Science paper that was published yesterday.

Clinical Trials


Beyond Medicine

CRISPR Medicine Jobs is Here!

We recently launched the first targeted recruitment platform for CRISPR-related jobs. Prospective employers and job seekers from all over the world can use this unique platform to find highly skilled scientists and exciting jobs within the CRISPR Medicine field!

Check out the first external job posting from the Hendel Lab in Israel right here.

Thank you for now - more great reads are on the way!

And if you have questions or suggestions, you can reach out to us directly at We love hearing from readers!

Happy Reading!


p.s. You can follow CRISPR Medicine News on Twitter and LinkedIn. If someone forwarded this email to you, you can sign up for our newsletter yourself here.